1. A method of treating an inflammatory condition of the intestine, comprising a step in which a composition comprising at least one active agent and a probiotic is administered to a mammal in need of such therapy. ! 2. The method according to claim 1, characterized in that said active agent is selected from the group consisting of: aminosalicylate, sulfasalazine, 5-aminosalicylic acid, 4-aminosalicylic acid, benzalazine, dihydrochloride, olsalazine, balsalazide, basic bismuth salicylate and mixtures thereof . ! 3. The method according to claim 1, characterized in that said composition contains from about 1 mg to about 8000 mg of said active agent. ! 4. The method according to claim 1, characterized in that said composition contains from about 200 mg to about 4800 mg of said active agent. ! 5. The method according to claim 1, characterized in that said probiotic is Bifidobacterium spp. ! 6. The method according to claim 5, characterized in that the said Bifidobacterium spp. contain bacteria selected from the group consisting of Bifidobacterium longum, Bifidobacterium infantis, Bifidobacterium bifidum, and mixtures thereof. ! 7. The method according to claim 5, characterized in that said Bifidobacterium spp. contain Bifidobacterium infantis. ! 8. The method according to claim 5, characterized in that the single dose of the probiotic contains at least about 105 cfu Bifidobacterium spp. ! 9. The method of claim 8, wherein the single dose of the probiotic contains from about 108 cfu to about 1012 cfu of Bifidobacterium spp. ! 10. The method according to claim 1, characterized in that the inflammatory condition of the intestine is selected from the group consisting of inflammatory irritable bowel syndrome, irritable bowel syndrome-diarrhea, irritable bowel syndrome-constipation, irritable bowel syndrome mixed, syndrome1. Способ терапии воспалительного состояния кишечника, включающий стадию, на которой вводят млекопитающему, нуждающемуся в такой терапии, композицию, содер
